Home | BSAAM's Organizer | BSAAM's Sponsor | London Accommodation Info | Contact Us
BSAAM's Anti Ageing Conference London 2019
Follow us on ...
Facebook  Twitter  Instagram
Conference Information
Download 2018 Feedback Form (Required for Credits)
Pre-conference Presentations
2018 Program
2018 Speaker List & Presentation Download
Speaker Videos
2018 Pre-Conference Workshops
2018 Exhibitors
2018 Peer Review Board Members
Delegate Information
2018 VENUE: The Kensington Town Hall - MAP
Nearby London Accommodations
A4M Board Certification
  American Board Of Anti-Aging/Regenerative Medicine (ABAARM)
Past Conference Information
2017 Speakers and Presentations
2017 Programme
2017 Exhibitors

BSAAMs AACL 2017 Peer Review Board Members
2016 Speakers and Presentations
2016 Programme
2016 Exhibitors
2016 Moderators
BSAAMs AACL 2016 Peer Review Board Members
2015 Speakers and Presentations
2015 Programme
2015 Exhibitors
2015 Moderators
BSAAMs AACL 2015 Peer Review Board Members
2014 Speakers and Presentations
2014 Programme
2014 Exhibitors
2014 Moderators
2014 Peer Review Board Members
2014 Aesthetic Peer Review Board Members
2013 Speakers and Presentations
2013 Programme
2013 Exhibitors
2013 Moderators
2013 Peer Review Board Members
2013 Aesthetic Peer Review Board Members
2012 Speakers and Presentations
2012 Programme
2012 Exhibitors
2012 Moderators
2012 Peer Review Board Members
2012 Aesthetic Peer Review Board Members
2011 Speakers and Presentations
2011 Programme
2011 Exhibitors
2011 Moderators
2011 Peer Review Board Members
2011 Aesthetic Peer Review Board Members
2010 Conference Manual
2010 Speakers and Presentations
2010 Programme
2010 Exhibitors
2010 Moderators
2010 Peer Review Board Members
2010 Aesthetic Peer Review Board Members
Programme for the 2009
Exhibitors for the 2009
Speakers for the 2009
2009 Peer Review Board Members
2009 Aesthetic Peer Review Board Members
Programme for 2008
Exhibitors for 2008
Speakers for 2008
2008 Peer Review Board Members
2008 Aesthetic Peer Review Board Members
  2007 Speaker List
2007 Speaker Programme
  Pre Conference Workshops
Sept 12 Pre-Conference Workshop Programme
Sept 13 Pre-Conference Workshop Programme
  2007 Peer Review Board Members
  Exhibitors for 2007
  3rd Annual Anti-Ageing Conference Manual (2006)
  Programme for 2006
  ISRM2006 Scientific Board Members
  2006 Peer Review Board Members
  Exhibitors 2006
  Post Review of 2005
  Remarks about 2005
  Peer Review Board of 2005
  Past Speakers 2005
  Past Speakers 2004
  Past Speakers Monte Carlo 2002
BSAAM's AACL Organizer
BSAAM Affiliates
AACL Supporters
HB Health
  Sun Chlorella

AACL 2010 Speaker

WeberProf Dr Bernard Weber

A medical doctor and CEO of Laboratoires Réunis, a private medical laboratory based in Luxembourg, Europe. Laboratoires Réunis is a national leader in the field of predictive genetics and molecular diagnosis of infectious diseases and is ISO 15189 accredited since 2006. In the last five years Dr Weber and his team have developed and validated a unique panel of phenotypic and genotypic markers which constitute a very important tool for the integrative approach of multifactorial and environment linked diseases.

Genetic Analysis of Different SNPs as Potential Biomarkers in Colorectal Cancer
Genetic analysis of different SNPs (single nucleotide polymorphisms) as potential prognostic biomarkers in CRC (colorectal cancer) – a pilot study -

Laboratoires Réunis, Junglinster, Luxembourg; 2Laboratoire de Recherche sur le Cancer et les Maladies du Sang, Luxembourg

Colorectal cancer (CRC) occurs either in the colon or rectum. It is the third most common cancer and the second leading cause of cancer-related death in Western Europe. The average lifetime risk of developing CRC is about 5%. Any factor leading to increased cell division in the large intestine can potentially increase the probability of developing CRC. Environmental factors such as a diet that is poor in vegetables and rich in fat may promote cell growth. Additionally cigarette smoke, excessive alcohol consumption and inflammatory bowel disorders such as Crohn’s disease and ulcerative colitis are known to cause overgrowth of colon cells. The majority of CRCs are sporadic cases whereas about 25% of the cases have an inherited compound. Mutations in the genes MSH2 and MLH1 account for only one fifth of the inherited cases of  CRC. The rest of the individual colorectal cancer risk is probably due to common genetic variants that, individually, do not contribute much to an increased risk of CRC. However the presence of many variants of these SNPs can contribute to the  development of the disease. In this case, the risk can be largely reduced by changing the lifestyle.

In the present study, SNPs related to cell gowth and divison were analysed in 100 patients withan advanced CRC. The carcinomas had a histological staining equal or greater than pT1 and were thus belonging to the adenoma-carcinoma or to the carcinoma stage. The control group consisted of 100 patient not carrying a CRC. Genotyping was performed by melting curve analysis on DNA isolated from whole blood-samples.

The analysed SNPs were: p53 (rs1042522), MDM2 (rs2279744), TGFBR1 (rs334348, rs334349, rs1590), TGFBR4 (rs7871490), SMAD7 (rs4464148, rs12953717, rs493927), PROC3 (rs6983267), FLJ (rs3802842), CHR9 (rs719725) and CHR8 (rs7014346).

Our results show that especially polymorphisms related to TGFBR and SMAD7 seem to be promising CRC predispostion markers. Further studies, which focus on sequencing of the complete genes, will elucidate which role spontaneous mutations as well as known and newly discovered polymorphisms play in the development of CRC.

View .pdf of Presentation here!

Home | BSAAM's Organizer | BSAAM's Sponsor | London Accommodation Info | Contact Us
BSAAM's Anti Ageing Conference London, 38 Regent on the River
William Morris Way London SW6 2UT, United Kingdom
Tel: +44 (0)79 7317 3478  Fax: +44 (0)20 7491 0410
Emails :